Press Releases

Press Release – Update on Valsartan API – A Statement from the Company

Aug 21, 2018 15:20

FOR IMMEDIATE RELEASE - CRANBURY, NEW JERSEY, August 21, 2018. Huahai US Inc., a subsidiary of Zhejiang Huahai Pharmaceutical Co. Ltd is issuing a statement. Recent articles in several print...

Read more

SOLCO HEALTHCARE US ANNOUNCES THE LAUNCH OF ENTECAVIR TABLETS

Apr 25, 2018 17:09

CRANBURY, NJ., April 25, 2018 – Solco Healthcare is proud to announce the launch of Entecavir Tablets, 0.5mg and 1mg, a generic equivalent of Baraclude® Tablets by Bristol-Myers Squibb Company. ...

Read more

SOLCO HEALTHCARE US ANNOUNCES THE LAUNCH OF CLONIDINE HCL ER TABLETS

Apr 03, 2018 17:35

Cranbury, NJ., April 3, 2018.  Solco Healthcare announced today the launch of Clonidine Hydrochloride Extended-Release Tablets, 01.mg, a generic version of Kapvay® Tablets by Concordia Pharmaceuticals Inc.  The product is...

Read more

Solco Healthcare US receives FDA approval for its generic to Abilify® tablets

Mar 01, 2018 19:52

CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Abilify® Tablets (Aripiprazole tablets), 2, 5, 10...

Read more

Solco Healthcare US Announces the FDA Approval for its generic to Hyzaar® Tablets

Feb 28, 2018 22:02

CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Hyzaar® Tablets (Losartan Potassium and Hydrochlorothiazide tablets)...

Read more

Solco News

Here you will find useful healthcare related information and latest industry news, including exclusive content available only on Solco News.


Archives

2018 2017 2016